10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,550,000 | -78.4% | 211,050 | -63.6% | 0.22% | -49.1% |
| Q1 2022 | $44,153,000 | -24.4% | 580,439 | +48.1% | 0.44% | -10.8% |
| Q4 2021 | $58,396,000 | -51.0% | 392,025 | -52.1% | 0.49% | -35.1% |
| Q3 2021 | $119,204,000 | -33.6% | 818,826 | -10.7% | 0.76% | -26.3% |
| Q2 2021 | $179,572,000 | +17.9% | 917,030 | +8.9% | 1.03% | +18.5% |
| Q1 2021 | $152,358,000 | – | 841,757 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |